Compared to CD8+ T cells from untreated MSI CRC, only the long-term immunosurveillance signaling module showed significant increase in CD8+ T cells from anti-PD-1-treated MSI CRC (Fig. 7d). This evidence concerns the gene CD8A and colorectal carcinoma.